Literature DB >> 15615525

1,3,4-thiadiazole derivatives. Synthesis, structure elucidation, and structure-antituberculosis activity relationship investigation.

Elçin E Oruç1, Sevim Rollas, Fatma Kandemirli, Nathaly Shvets, Anatholy S Dimoglo.   

Abstract

A series of 2,5-disubstituted-1,3,4-thiadiazoles were synthesized, the compounds structures were elucidated and screened for the antituberculosis activity against Mycobacterium tuberculosis H37Rv using the BACTEC 460 radiometric system. Among the tested compounds, 2-phenylamino-5-(4-fluorophenyl)-1,3,4-thiadiazole 22 showed the highest inhibitory activity. The relationships between the structures of compounds and their antituberculosis activity were investigated by the Electronic-Topological Method (ETM) and feed forward neural networks (FFNNs) trained with the back-propagation algorithm. As a result of the approach, a system of pharmacophores and anti-pharmacophores has been found that effectively separates compounds of the examination set into groups of active and inactive compounds. The system can be applied to the screening and design of new active compounds possessing skeletons similar to those used in the present study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15615525     DOI: 10.1021/jm0495632

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  20 in total

1.  Pharmacophore Mapping Approach for Drug Target Identification: A Chemical Synthesis and in Silico Study on Novel Thiadiazole Compounds.

Authors:  Rohan J Meshram; Vijay B Baladhye; Rajesh N Gacche; Bhausaheb K Karale; Rajendra B Gaikar
Journal:  J Clin Diagn Res       Date:  2017-05-01

2.  ETM-ANN approach application for thiobenzamide and quinolizidine derivatives.

Authors:  M Saracoglu; F Kandemirli; V Kovalishyn; T Arslan; E E Ebenso
Journal:  J Biomed Biotechnol       Date:  2010-09-07

3.  Thiazolidinone CFTR inhibitors with improved water solubility identified by structure-activity analysis.

Authors:  N D Sonawane; A S Verkman
Journal:  Bioorg Med Chem       Date:  2008-07-23       Impact factor: 3.641

4.  Microbiologically active Mannich bases derived from 1,2,4-triazoles. The effect of C-5 substituent on antibacterial activity.

Authors:  Tomasz Plech; Monika Wujec; Magdalena Majewska; Urszula Kosikowska; Anna Malm
Journal:  Med Chem Res       Date:  2012-09-29       Impact factor: 1.965

5.  [5-(4-Bromo-phenoxy-meth-yl)-1,3,4-thia-diazole-2-thiol-ato]triphenyl-tin(IV).

Authors:  Zhi-Feng Wang; Gui-Long Zhao; Lai-Jin Tian
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-04-18

6.  5-(3-Nitro-benz-yl)-1,3,4-thia-diazol-2-amine.

Authors:  Samir A Carvalho; Larisse O de Feitosa; Edson F da Silva; Edward R T Tiekink; James L Wardell; Solange M S V Wardell
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-11-25

7.  2-Methyl-5-[(3-methyl-4-nitro-benz-yl)sulfan-yl]-1,3,4-thia-diazole.

Authors:  Hoong-Kun Fun; Suchada Chantrapromma; B Chandrakantha; Arun M Isloor; Prakash Shetty
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-12-24

8.  Synthesis of 5-arylidine amino-1,3,4-thiadiazol-2-[(N-substituted benzyol)]sulphonamides endowed with potent antioxidants and anticancer activity induces growth inhibition in HEK293, BT474 and NCI-H226 cells.

Authors:  Mahavir Chhajed; Anil Kumar Shrivastava; Vijay Taile
Journal:  Med Chem Res       Date:  2013-12-27       Impact factor: 1.965

9.  Synthesis, characterization, antimicrobial, and pharmacological evaluation of some 2, 5-disubstituted sulfonyl amino 1,3,4-oxadiazole and 2-amino-disubstituted 1,3,4-thiadiazole derivatives.

Authors:  Dilipkumar Pal; Rohit Tripathi; Desh Deepak Pandey; Preety Mishra
Journal:  J Adv Pharm Technol Res       Date:  2014-10

10.  N-[4-Acetyl-5-(4-fluoro-phen-yl)-4,5-di-hydro-1,3,4-thia-diazol-2-yl]acetamide.

Authors:  H D Kavitha; Sheetal B Marganakop; Ravindra R Kamble; K R Roopashree; H C Devarajegowda
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.